Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus topiramate for opioid withdrawal syndrome
IRCT20210427051102N1Phase 3Completed
- Sponsor
- Fasa University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of gabapentin and topiramate in opioid withdrawal (2 arms), sponsored by Fasa University of Medical Sciences. Primary endpoint: Opioid withdrawal syndrome score at day 11. Started Jun 2021; status: completed.
02
Drugs
gabapentintopiramate
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on IRCT20210427051102N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210427051102N1.